IO Biotech Ownership | Who Owns IO Biotech?
IO Biotech Ownership Summary
IO Biotech is owned by 35.78% institutional investors, 0.24% insiders, and 63.98% retail investors. Vivo capital is the largest institutional shareholder, holding 9.37% of IOBT shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.99% of its assets in IO Biotech shares.
IOBT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | IO Biotech | 35.78% | 0.24% | 63.98% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vivo capital | 6.17M | 9.37% | $7.22M |
| Novo | 4.43M | 6.72% | $5.18M |
| Samsara biocapital | 3.64M | 5.53% | $4.26M |
| Pfm health sciences, lp | 2.34M | 3.55% | $2.74M |
| Marshall wace, llp | 2.11M | 3.20% | $2.46M |
| Morgan stanley | 1.97M | 2.99% | $2.31M |
| Bank of america corp /de/ | 1.65M | 2.51% | $1.93M |
| Alyeska investment group | 987.65K | 1.50% | $1.16M |
| Pivotal bioventure partners investment advisor | 864.20K | 1.31% | $1.01M |
| Logos global management lp | 493.83K | 0.75% | $577.78K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 3.64M | 0.89% | $4.26M |
| Pivotal bioventure partners investment advisor | 864.20K | 0.78% | $1.01M |
| Vivo capital | 6.17M | 0.67% | $7.22M |
| Novo | 4.43M | 0.26% | $5.18M |
| Pfm health sciences, lp | 2.34M | 0.14% | $2.74M |
| Logos global management lp | 493.83K | 0.05% | $577.78K |
| Soleus capital management | 192.67K | 0.02% | $225.42K |
| Alyeska investment group | 987.65K | 0.01% | $1.16M |
| Bridgeway capital management | 124.62K | 0.00% | $145.81K |
| Marshall wace, llp | 2.11M | 0.00% | $2.46M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 192.67K | 0.02% | 192.67K |
| Citadel advisors | 86.89K | - | 28.27K |
| Renaissance | 180.80K | 0.00% | 13.60K |
| Ubs group | 3.28K | - | 3.28K |
| Marshall wace, llp | 2.11M | 0.00% | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -1.54M |
| Novo | 4.43M | 0.26% | -658.81K |
| Fmr | - | - | -314.60K |
| Morgan stanley | 1.97M | 0.00% | -224.89K |
| Bank of america corp /de/ | 1.65M | 0.00% | -192.67K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Soleus capital management | 192.67K | 0.02% | 192.67K | $225.42K |
Sold Out
| Holder | Change |
|---|---|
| Redwood wealth management group | -4.17K |
| Xtx topco | -26.55K |
| Stonepine capital management | -156.17K |
| Fmr | -314.60K |
| Armistice capital | -1.54M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 18 | -10.00% | 23,573,928 | -9.96% | 35 | 2.27% | 7 | 16.67% | 2 | -50.00% |
| Jun 30, 2024 | 20 | 11.11% | 26,183,049 | -4.24% | 39 | 1.01% | 6 | 20.00% | 4 | -20.00% |
| Mar 31, 2024 | 18 | -5.26% | 27,341,910 | -7.00% | 62 | 1.83% | 5 | -28.57% | 5 | 25.00% |
| Dec 31, 2023 | 19 | -5.00% | 29,400,721 | -0.90% | 58 | 0.55% | 7 | -41.67% | 4 | 100.00% |
| Sep 30, 2023 | 20 | 33.33% | 29,668,665 | 142.26% | 102 | 5.70% | 12 | 100.00% | 2 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 3.94M | 5.99% | - |
| MEDICAL BioHealth EUR Acc | 679.10K | 1.03% | 7.40K |
| Fidelity Select Biotechnology | 314.60K | 0.48% | - |
| Bridgeway Ultra-Small Company Market | 199.00K | 0.30% | 75.00K |
| Fidelity Nasdaq Composite Index | 33.31K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 26, 2024 | Novo Holdings A/S | - | Sell | $30.79K |
| Jul 25, 2024 | Novo Holdings A/S | - | Sell | $68.34K |
| May 10, 2024 | Novo Holdings A/S | - | Sell | $802.50K |
| Feb 09, 2024 | Novo Holdings A/S | - | Sell | $988.41K |
| Nov 22, 2023 | Burkavage Brian | Chief Accounting Officer | Buy | $5.17K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 1 |
| 2023 Q4 | 2 | - |
| 2023 Q3 | 4 | - |
IOBT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools